Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Published in: Clinical Research in Cardiology 3/2019

01-03-2019 | Review

Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function

Authors: Agata Bielecka-Dabrowa, Breno Godoy, Tsuyoshi Suzuki, Maciej Banach, Stephan von Haehling

Published in: Clinical Research in Cardiology | Issue 3/2019

Login to get access

Abstract

The prevalence of subclinical hypothyroidism (SCH) ranges from 5 to 15% of the general population. However, it remains controversial if SCH warrants life-long thyroxine replacement therapy. Patients with a thyroid-stimulating hormone (TSH) level > 10 mIU/L have a higher risk of developing heart failure with reduced ejection fraction as compared to subjects with normal thyroid function. However, abnormally high TSH levels could also be connected with an overall lower metabolic rate and better survival in elderly subjects. The potential mechanisms responsible for diastolic dysfunction of the left ventricle (LV) in SCH are connected with endothelial dysfunction and arterial stiffness, inflammatory state and are driven by TSH apoptosis-derived microparticles. The impact of SCH on LV systolic function is more controversial, and it is connected not only with cardiac remodelling but also with predisposition of patients with SCH to the conditions leading to heart failure. This review presents an overview of processes in the context of potential benefits of thyroxine supplementation therapy.
Literature
1.
2.
Ripoli A, Pingitore A, Favilli B et al (2005) Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. J Am Coll Cardiol 45:439–445CrossRefPubMed
3.
Redford C, Vaidya B (2017) Subclinical hypothyroidism: should we treat? Post Reprod Health 23:55–62CrossRefPubMed
4.
Störk S, Handrock R, Jacob J et al (2017) Epidemiology of heart failure in Germany: a retrospective database study. Clin Res Cardiol 106(11):913–922CrossRefPubMedPubMedCentral
5.
Rodondi N, Newman AB, Vittinghoff E et al (2005) Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165:2460–2466CrossRefPubMed
6.
Biondi B (2012) Mechanisms in endocrinology: Heart failure and thyroid dysfunction. Eur J Endocrinol 167(5):609–618CrossRefPubMed
7.
8.
Gencer B, Collet TH, Virgini V et al (2012) Thyroid Studies C. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation 126:1040–1049CrossRefPubMed
9.
10.
Parretti H, Okosieme O, Vanderpump M (2016) Current recommendations in the management of hypothyroidism: developed from a statement by the British Thyroid Association Executive. Br J Gen Pract 66:538–540CrossRefPubMedPubMedCentral
11.
Floriani C, Gencer B, Collet TH, Rodondi N (2018) Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update. Eur Heart J 14(7):503–507 39(CrossRef
12.
Chen S, Shauer A, Zwas DA, Lotan C, Keren A, Gotsman I (2014) The effect of thyroid function on clinical outcome in patients with heart failure. Eur J Heart Fail 16(2):217–226CrossRefPubMed
13.
Gencer B, Collet TH, Virgini V, Auer R, Rodondi N (2013) Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies. Endocr Metab Immune Disord Drug Targets 13:4–12CrossRefPubMed
14.
Hayashi T, Hasegawa T, Kanzaki H et al (2016) Subclinical hypothyroidism is an independent predictor of adverse cardiovascular outcomes in patients with acute decompensated heart failure. ESC Heart Fail 3:168–176CrossRefPubMedPubMedCentral
15.
Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG (2004) Thyroid status, disability and cognitive function, and survival in old age. JAMA 292:2591–2599CrossRefPubMed
16.
Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Rev Esp Cardiol (Engl Ed 69:1167
17.
Lam CS, Lyass A, Kraigher-Krainer E et al (2011) Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation 124:24–30CrossRefPubMedPubMedCentral
18.
Hammoudi N, Laveau F, Helft G et al (2017) Low level exercise echocardiography helps diagnose early stage heart failure with preserved ejection fraction: a study of echocardiography versus catheterization. Clin Res Cardiol 106(3):192–201CrossRefPubMed
19.
Morbach C, Buck T, Rost C et al (2018 Feb) Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study. Clin Res Cardiol 107(2):95–107CrossRefPubMed
20.
Vitale G, Maurizio G, Gelsy AL et al (2002) Left ventricular myocardial impairment in subclinical hypothyroidism assessed by a new ultrasound tool: pulsed tissue Doppler. J Clin Endocrinol Metab 87:4350–4355CrossRefPubMed
21.
Zoncu S, Pigliaru F, Putzu C et al (2005) Cardiac function in borderline hypothyroidism: a study by pulsed wave tissue doppler imaging. Eur J Endocrinol 152:527–533CrossRefPubMed
22.
Biondi B, Fazio S, Palmieri EA et al (1999) Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 84:2064–2067CrossRefPubMed
23.
Rodondi N, Bauer DC, Cappola AR et al (2008) Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. J Am Coll Cardiol 52:1152–1159CrossRefPubMedPubMedCentral
24.
Biondi B, Palmieri EA, Lombardi G, Fazio S (2002) Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 137:904–914CrossRefPubMed
25.
Biondi B, Palmieri EA, Lombardi G, Fazio S (2002) Subclinical hypothyroidism and cardiac function. Thyroid 12:505–510CrossRefPubMed
26.
Arem R, Rokey R, Kiefe C, Escalante DA, Rodriguez A (1996) Cardiac systolic and diastolic function at rest and exercise in subclinical hypothyroidism: effect of thyroid hormone therapy. Thyroid 6:397–402CrossRefPubMed
27.
Weber T, O’Rourke MF, Ammer M, Kvas E, Punzengruber C, Eber B (2008) Arterial stiffness and arterial wave reflections are associated with systolic and diastolic function in patients with normal ejection fraction. Am J Hypertens 21:1194–1202CrossRefPubMed
28.
Desai AS, Mitchell GF, Fang JC, Creager MA (2009) Central aortic stiffness is increased in patients with heart failure and preserved ejection fraction. J Card Fail 15:658–664CrossRefPubMed
29.
Kang S, Fan HM, Li J et al (2010) Relationship of arterial stiffness and early mild diastolic heart failure in general middle and aged population. Eur Heart J 31:2799–2807CrossRefPubMed
30.
Paglia A, Sasso L, Pirozzi F et al (2014) Arterial wave reflections and ventricular–vascular interaction in patients with left ventricular systolic dysfunction. Int Heart J 55:526–532CrossRefPubMed
31.
Lüers C, Trippel TD, Seeländer S et al (2017) Arterial stiffness and elevated left ventricular filling pressure in patients at risk for the development or a previous diagnosis of HF-A subgroup analysis from the DIAST-CHF study. J Am Soc Hypertens 11(5):303–313CrossRefPubMed
32.
McEniery CM, Wallace S, Mackenzie IS et al (2006) Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension 48:602–608CrossRefPubMed
33.
34.
Nagasaki T, Inaba M, KumedaY et al (2005) Increased pulse wave velocity in subclinical hypothyroidism. J Clin Endocrinol Metab 91:154–158CrossRefPubMed
35.
Masaki M, Komamura K, Goda A et al (2014) Elevated arterial stiffness and diastolic dysfunction in subclinical hypothyroidism. Circ J 78(6):1494–1500CrossRefPubMed
36.
Owen PJ, Rajiv C, Vinereanu D, Mathew T, Fraser AG, Lazarus JH (2006) Subclinical hypothyroidism, arterial stiffness, and myocardial reserve. J Clin Endocrinol Metab 91(6):2126–2132CrossRefPubMed
37.
Mause SF, Weber C (2010) Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 107(9):1047–1057CrossRefPubMed
38.
Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS (2006) Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 39(8):683–690CrossRefPubMed
39.
Nozaki T, Sugiyama S, Sugamura K et al (2010) Prognostic value of endothelial microparticles in patients with heart failure. Eur J Heart Fail 12(11):1223–1228CrossRefPubMed
40.
Yong PJ, Koh CH, Shim WS (2013) Endothelial microparticles: missing link in endothelial dysfunction? Eur J Prev Cardiol 20(3):496–512CrossRefPubMed
41.
Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA, Berezina TA (2015) The association of subclinical hypothyroidism and pattern of circulating endothelial-derived microparticles among chronic heart failure patients. Res Cardiovasc Med 4(4):e29094CrossRefPubMedPubMedCentral
42.
Berezin AE, Kremzer AA, Martovitskaya YV et al (2015) The predictive role of circulating microparticles in patients with chronic heart failure. BBA Clin 3:18–24CrossRefPubMed
43.
Berezin AE, Kremzer A, Berezina T, Martovitskaya Y (2016) The signature of circulating microparticles in heart failure patients with metabolic syndrome. J Circ Biomark 5:1849454416663659PubMedPubMedCentral
44.
Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA, Berezina TA (2016) Pattern of circulating endothelial-derived microparticles among chronic heart failure patients with dysmetabolic comorbidities: the impact of subclinical hypothyroidism. Diabetes Metab Syndr 10(1):29–36CrossRefPubMed
45.
Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271CrossRefPubMed
46.
Maaten JM, Damman K, Verhaar MC et al (2016) Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation. Eur J Heart Fail 18:588–598CrossRefPubMed
47.
Gupta G, Sharma P, Kumar P, Itagappa M (2015) Study on subclinical hypothyroidism and its association with various inflammatory markers. J Clin Diagn Res 9(11):BC04–B6PubMedPubMedCentral
48.
Vaya A, Gimenez C, Sarnago A et al (2014) Subclinical hypothyroidism and cardiovascular risk. Clin Hemorheol Microcirc 58:1–7PubMed
49.
Taddei S, Caraccio N, Virdis A et al (2006) Low grade systemic inflammation causes endothelial dysfunction in patients with hashimato’s thyroiditis. J Clin Endocrinol Metab 91:5076–5082CrossRefPubMed
50.
51.
Türemen EE, Çetinarslan B, Sahin T, Cantürk Z, Tarkun I (2011) Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocr J 58:349–354CrossRefPubMed
52.
Walsh JP, Bremner AP, Bulsara MK et al (2005) Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 165:2467–2472CrossRefPubMed
53.
Pesic MM, Radojkovic D, Antic S, Kocic R, Stankovic-Djordjevic D (2015) Subclinical hypothyroidism: association with cardiovascular risk factors and components of metabolic syndrome. Biotechnol Biotechnol Equip 29:157–163CrossRefPubMed
54.
Ilic S, Tadic M, Ivanovic B, Caparevic Z, Trbojevic B, Celic V (2013) Left and right ventricular structure and function in subclinical hypothyroidism: the effects of one-year levothyroxine treatment. Med Sci Monit 10:19:960–968
55.
Monzani F, Di Bello V, Caraccio N et al (2001) Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab 86(3):1110–1115CrossRefPubMed
56.
Mishra TK, Routray SN, Das S, Behera M (2005) Left ventricular dysfunction in patients with subclinical hypothyroidism and its reversibility after hormone therapy. J Assoc Physicians India 53:943–946PubMed
57.
Aghini-Lombardi F, Di Bello V, Talini E et al (2006) Early textural and functional alterations of left ventricular myocardium in mild hypothyroidism. Eur J Endocrinol 155:3–9CrossRefPubMed
58.
Iqbal A, Schirmer H, Lunde P et al (2007) Thyroid stimulating hormone and left ventricular function. J Clin Endocrinol Metab 92:3504–3510CrossRefPubMed
59.
McDermott MM, Feinglass J, Sy J, Gheorghiade M (1995) Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: Clinical characteristics and drug therapy. Am J Med 99:629–635CrossRefPubMed
60.
Bell GM, Todd WT, Forfar JC et al. End-organ responses to thyroxine therapy in subclinical hypothyroidism. Clin Endocrinol (Oxf) 22:83–89
61.
Kahaly GJ (2000 Aug) Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 10(8):665–679CrossRefPubMed
62.
Kirchhof G, Lindner JF, Achenbach S et al (2018 Mar) Stratified prevention: opportunities and limitations. Report on the 1st interdisciplinary cardiovascular workshop in Augsburg. Clin Res Cardiol 107(3):193–200CrossRefPubMed
63.
Störk S, Handrock R, Jacob J et al (2017) Treatment of chronic heart failure in Germany: a retrospective database study. Clin Res Cardiol 106(11):923–932CrossRefPubMedPubMedCentral
64.
Stott DJ, Rodondi N, Kearney PM, TRUST Study Group (2017) Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. N Engl J Med 376:2534–2544CrossRefPubMed
65.
Vadiveloo T, Donnan PT, Murphy MJ, Leese GP (2013) Age- and gender-specific TSH reference intervals in people with no obvious thyroid disease in Tayside, Scotland: the Thyroid Epidemiology, Audit, and Research Study (TEARS). J Clin Endocrinol Metab 98:1147–1153CrossRefPubMed
66.
Waring AC, Arnold AM, Newman AB, Buzkova P, Hirsch C, Cappola AR (2012) Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab 97:3944–3950CrossRefPubMedPubMedCentral
67.
Surks MI, Boucai L (2010) Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab 95:496–502CrossRefPubMed
68.
Surks MI, Hollowell JG (2007) Age-specific distribution of serum thyrotropin and antithyroid antibodies in the U.S. population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 92:4575–4582CrossRefPubMed
69.
70.
Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT (2005) Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 90:581–585CrossRefPubMed
71.
Cooper DS, Biondi B (2012) Subclinical thyroid disease. Lancet 379:1142–1154CrossRef
72.
Rhee SS, Pearce EN (2011) Update: Systemic Diseases and the Cardiovascular System (II). The endocrine system and the heart: a review. Rev Esp Cardiol 64:220–231CrossRefPubMed
Metadata
Title
Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function
Authors
Agata Bielecka-Dabrowa
Breno Godoy
Tsuyoshi Suzuki
Maciej Banach
Stephan von Haehling
Publication date
01-03-2019
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 3/2019
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-018-1340-1

Other articles of this Issue 3/2019

Clinical Research in Cardiology 3/2019 Go to the issue

Letter to the Editors

Plasma FGF23 does not rise during physical exercise as a physiological model of sympathetic activation

Original Paper

Symptom patterns and clinical outcomes in women versus men with systolic heart failure and depression

Original Paper

Predictors of mortality in ischaemic versus non-ischaemic functional mitral regurgitation after successful transcatheter mitral valve repair using MitraClip: results from two high-volume centres

Original Paper

Clinical and economical impact of the presence of an extended heart team throughout the balloon-expandable transcatheter aortic valve implantation procedure

Letter to the Editors

Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation

Original Paper

Extended ECG monitoring with an implantable loop recorder in patients with cryptogenic stroke: time schedule, reasons for explantation and incidental findings (results from the TRACK-AF trial)

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits